Figure 1.
Study treatment plan by cohort. The treatment planned for each of the 9 cohorts is shown. Cohorts were recruited sequentially, that is, when enough patients entered a cohort and were assessed a new cohort was opened. Cohort 7 and 8 included patients who had different induction chemotherapy schedules without GO. In cohort 7, 3 patients received H-DAT, 8 received S-DAT, 4 received DA, and 3 received FLAG-Ida. In cohort 8, 7 patients received FLAG-Ida, 4 received DA, and 2 received S-DAT. In cohort 9, 7 patients received DA, 10 received FLAG-Ida, and 6 received S-DAT as induction with GO 3 mg/m2. Of these 23 patients, 13 received MACE with GO and 10 received HidAC with GO as course 3.
